Israeli Study Finds Molecule Triggers Self-Destruction Of Pancreatic Cancer Cells
The administration of PJ34 reduced the number of cancer cells in developed tumors in mice by up to 90 percent in 30 days, Israeli scientists say.
December 03, 2019
Israeli Oncologist Offers Hope With New Treatment For Some Pancreatic Cancer Patients
A new drug treatment regimen in a clinical study at the Sheba Medical Center showed that the disease could be stalled significantly for patients with advanced stages of pancreatic cancer with a BRCA germline mutation.
July 02, 2019
‘Tiltan Pharma’ Starts Phase II Trial For Pancreatic Cancer Drug
Tiltan Pharma Ltd. announced it has started phase II of its clinical trial for its new drug for pancreatic cancer, following approval by the Israeli Ministry of Health. The drug is designed to prevent blood flow to tumors and prevent their growth. The second phase of the trial will include 80 patients: 40 with newly […]
February 16, 2012